Profound Medical (NASDAQ:PROF; TSX:PRN) has announced that five abstracts presented at the 15th Interventional MRI (iMRI) Symposium in Boston, Massachusetts, reinforce the growing body of evidence supporting the real...
Organogenesis Holdings (NASDAQ: ORGO) has announced the publication of peer-reviewed trial results in the Journal of Wound Care (JWC) showing the clinical benefit of PuraPly AM for hard-to-treat diabetic foot ulcers...
Co-Diagnostics (NASDAQ: CODX) has announced that it has received an order from the Ute Indian Tribe Mosquito Abatement Department for a full Vector Smart mosquito surveillance laboratory installation. According to Co...
bioAffinity Technologies (NASDAQ: BIAF) has announced that the Japan Patent Office (JPO) has issued a notice of allowance (NOA) indicating its intention to grant a patent covering bioAffinity’s non-invasive lung cancer...
RenovoRX (NASDAQ: RNXT) has announced that the first patient has enrolled in PRISM-TAMP, an investigator-initiated trial sponsored by the University of Vermont (UVM) evaluating the approved chemotherapy gemcitabine...
PacBio (NASDAQ: PACB) and closely held TychoBio have announced a collaboration to generate full-length RNA data that TychoBio will use to train models for RNA therapy design. Under the terms of the agreement, TychoBio...
Saluda Medical (ASX: SLD) has announced the full U.S. commercial release of the FDA-approved CAP24 Surgical Paddle Lead making it available to neurosurgery and orthopedic spine practices in selected centers...
AIM ImmunoTech (NYSE American: AIM) is developing Ampligen, an immune modulator with potential applications across oncology, immune disorders, and viral diseases. The company is currently focused on developing Ampligen...
Valion Bio (NASDAQ: VBIO) has outlined the perspectives of its new board chair, Thomas H. Jensen, on advancing Entolimod—an investigational Toll-like receptor 5 (TLR5) agonist being developed as a potential medical...
Closely held Wandercraft has announced the acquisition of Ekso Bionics from a subsidiary of ChronoScale Holdings Corporation (NASDAQ: CHRN), uniting two leaders in robotic mobility to form the world’s leading medical...